Cargando…
Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models
Drug-induced liver injury (DILI) is a challenging clinical event in medicine, particularly because of its ability to present with a variety of phenotypes including that of autoimmune hepatitis or other immune mediated liver injuries. Limited diagnostic and therapeutic tools are available, mostly bec...
Autores principales: | Gerussi, Alessio, Natalini, Ambra, Antonangeli, Fabrizio, Mancuso, Clara, Agostinetto, Elisa, Barisani, Donatella, Di Rosa, Francesca, Andrade, Raul, Invernizzi, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123708/ https://www.ncbi.nlm.nih.gov/pubmed/33925355 http://dx.doi.org/10.3390/ijms22094557 |
Ejemplares similares
-
The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities
por: Binatti, Eleonora, et al.
Publicado: (2022) -
The Emerging Interplay Between Recirculating and Tissue-Resident Memory T Cells in Cancer Immunity: Lessons Learned From PD-1/PD-L1 Blockade Therapy and Remaining Gaps
por: Gitto, Silvia, et al.
Publicado: (2021) -
Regulation of PD-L1 Expression by NF-κB in Cancer
por: Antonangeli, Fabrizio, et al.
Publicado: (2020) -
OMIP‐079: Cell cycle of CD4
(+) and CD8
(+) naïve/memory T cell subsets, and of Treg cells from mouse spleen
por: Natalini, Ambra, et al.
Publicado: (2021) -
Food additives can act as triggering factors in celiac disease: Current knowledge based on a critical review of the literature
por: Mancuso, Clara, et al.
Publicado: (2019)